본문 바로가기
HOME> 논문 > 논문 검색상세

논문 상세정보

Molecular & cellular toxicology v.3 no.2, 2007년, pp.137 - 144  

Gene Expression Profiling of Doxifluridine Treated Liver, Small and Large Intestine in Cynomolgus (Macaca fascicularis) Monkeys

Jeong, Sun-Young   (Toxicogenomics Team, Korea Institute of ToxicologyCC0005493  ); Park, Han-Jin   (Toxicogenomics Team, Korea Institute of ToxicologyCC0005493  ); Oh, Jung-Hwa   (Toxicogenomics Team, Korea Institute of ToxicologyCC0005493  ); Kim, Choong-Yong   (Non-human Primate Research Team, Korea Institute of ToxicologyCC0005493  ); Yoon, Seok-Joo   (Toxicogenomics Team, Korea Institute of ToxicologyCC0005493  );
  • 초록

    The mechanism of cytotoxicity of doxifluridine, a prodrug fluorouracil (5-FU), has been ascribed to the misincorporation of fluoropyrimidine into RNA and DNA and to the inhibition of the nucleotide synthetic enzyme thymidylate synthase. Increased understanding of the mechanism of 5-FU has led to the development of strategies that increases its anticancer activity or predicts its sensitivity to patients. Using GeneChip?? Rhesus Macaque Genome arrays, we analyzed gene expression profiles of doxifluridine after two weeks repeated administration in cynomolgus monkey. Kegg pathway analysis suggested that cytoskeletal rearrangement and cell adhesion remodeling were commonly occurred in colon, jejunum, and liver. However, expression of genes encoding extracellular matrix was distinguished colon from others. In colon, COL6A2, COL18A1, ELN, and LAMA5 were over-expressed. In contrast, genes included in same category were down-regulated in jejunum and liver. Interestingly, MMP7 and TIMP1, the key enzymes responsible for ECM regulation, were overexpressed in colon. Several studies were reported that both gene reduced cell sensitivity to chemotherapy-induced apoptosis. Therefore, we suggest they have potential as target for modulation of 5-FU action. In addition, the expression of genes which have been previously known to involve in 5-FU pathway, were examined in three organs. Particularly, there were more remarkable changes in colon than in others. In colon, ECGF1, DYPD, TYMS, DHFR, FPGS, DUT, BCL2, BAX, and BAK1 except CAD were expressed in the direction that was good response to doxifluridine. These results may provide that colon is a prominent target of doxifluridine and transcriptional profiling is useful to find new targets affecting the response to the drug.

  • 주제어

    Doxifluridine .   Gene expression .   Liver .   Intestine .   5-FU.  

  • 참고문헌 (24)

    1. Terashima, M. et al. Role of thymidine phosphorylase and dihydropyrimidine dehydrogenase in tumor progression and sensitivity to doxifluridine in gastric cancer patients. Eur. J. Cancer 38:2375-2381 (2002) 
    2. Hasegawa, S. et al. Thymidine phosphorylase expression and efficacy of adjuvant doxifluridine in advanced colorectal cancer patients. Oncol. Rep. 13(4):621- 626 (2005) 
    3. Jinawath, N. et al. Comparison of gene-expression profiles between diffuse-and intestinal-type gastric cancers using a genome-wide cDNA microarray. Oncogene 23(40):6830-6844 (2004) 
    4. Yamamoto, H., Itoh, F., Hinoda, Y. & Imai, K. Suppression of matrilysin inhibits colon cancer cell invasion in vitro. Int. J. Cancer 61:218-222 (1995) 
    5. Sethi, T. et al. Extracellular matrix proteins protect small cell lung cancer against apoptosis: A mechanism for small cell lung cancer growth and drug resistance in vivo. Nat. Med. 5:662-668 (1999) 
    6. Douillard, J. Y. et al. Irinotecan combined with fluorouracil compared with fluorouracil alone as first-line treatment for metastatic colorectal cancer: a multicentre randomised trial. Lancet 355:1041-1047 (2000) 
    7. Sohn, K. J. et al. Effects of folylpolyglutamate synthetase modulation on chemosensitivity of colon cancer cells to 5-fluorouracil and methotrexate. Gut. 53(12):1825-1831 (2004) 
    8. Boudreau, N., Werb, Z. & Bissell, M. J. Suppression of apoptosis by basement membrane requires threedimensional tissue organization and withdrawal from the cell cycle. Proc. Natl. Acad. Sci. USA 93(8):3509- 3513 (1996) 
    9. Giacchetti, S. et al. Phase III multicenter randomized trial of oxaliplatin added to chronomodulated fluorouracilleucovorin as first-line treatment of metastatic colorectal cancer. J. Clin. Oncol. 18:136-147 (2000) 
    10. Kidd, E. A. et al. Variance in the expression of 5- Fluorouracil pathway genes in colorectal cancer. Clin. Cancer Res. 11(7):2612-2619 (2005) 
    11. Kono, A. et al. Activation of 5′-deoxy-5-fluorouridine by thymidine phosphorylase in human tumors. Chemo. Pharm. Bull. 31:175-178 (1983) 
    12. Davidsen, M. L. et al. TIMP-1 gene deficiency increases tumour cell sensitivity to chemotherapy-induced apoptosis. Br. J. Cancer 95(8):1114-1120 (2006) 
    13. Longley, D. B., Harkin, D. P. & Johnston, P. G. 5- fluorouracil: mechanisms of action and clinical strategies. Nat. Rev. Cancer 3:330-338 (2003) 
    14. Allegra, C. J. et al. Investigation of the prognostic and predictive value of thymidylate synthase, p53, and Ki-67 in patients with locally advanced colon cancer. J. Clin. Oncol. 20:1735-1743 (2002) 
    15. Mader, R. M., Muller, M. & Steger, G. G. Resistance to 5-fluorouracil. Gen. Pharmacol. 31(5):661-666 (1998) 
    16. Kornmann, M. et al. Thymidylate synthase and dihydropyrimidine dehydrogenase mRNA expression levels: predictors for survival in colorectal cancer patients receiving adjuvant 5-fluorouracil. Clin. Cancer Res. 9(11):4116-4124 (2003) 
    17. Schmidt, W. M. et al. Dissecting progressive stages of 5-fluorouracil resistance in vitro using RNA expression profiling. Int. J. Cancer 112(2):200-212 (2004) 
    18. Miyazaki, K. et al. Matrilysin as a target for chemotherapy for colon cancer: use of antisense oligonucleotides as antimetastatic agents. Cancer Chemother. Pharmacol. 43:S52-55 (1999) 
    19. Salonga, D. et al. Colorectal tumors responding to 5- fluorouracil have low gene expression levels of dihydropyrimidine dehydrogenase, thymidylate synthase, and thymidine phosphorylase. Clin. Cancer Res. 6: 1322-1327 (2000) 
    20. Taylor, S. T., Hickman, J. A. & Dive, C. Epigenetic determinants of resistance to etoposide regulation of Bcl-X(L) and Bax by tumor microenvironmental factors. J. Natl. Cancer Inst. 92:18-23 (2000) 
    21. Liu, J. J. et al. Heparin/heparan sulfate interacting protein plays a role in apoptosis induced by anticancer drugs. Carcinogenesis 25(6):873-879 (2004) 
    22. Ohtani, Y. et al. Suppression effects of human recombinant tissue inhibitor of metalloproteinases-1(TIMP- 1) on tumor proliferation using in vivo treatment model of well-differentiated colon cancer cell line, HT29. Acta Med. Okayama. 60(5):257-266 (2006) 
    23. Fingleton, B., Vargo-Gogola, T., Crawford, H. C. & Matrisian. L. M. Matrilysin [MMP-7] expression selects for cells with reduced sensitivity to apoptosis. Neoplasia 3(6):459-468 (2001) 
    24. O'Dwyer, P. J. et al. Phase II study of biochemical modulation of fluorouracil by low-dose PALA in patients with colorectal cancer. Clin. Oncol. 8(9):1497- 1503 (1990) 

 저자의 다른 논문

  • Jung, Sun-Young (3)

    1. 2005 "게잡이 원숭이에서 Recombinant Human Erythropoietin의 4주간 투여 후 비장 유전자 발현 연구" Journal of toxicology and public health : an official journal of the Korean Society of Toxicology 21 (3): 209~218    
    2. 2006 "Gene Expression Profiling of Early Renal Toxicity Induced by Gentamicin in Mice" Molecular & cellular toxicology 2 (3): 185~192    
    3. 2006 "Identification of Gene-based Potential Biomarkers for Cephalexin-induced Nephrotoxicity in Mice" Molecular & cellular toxicology 2 (3): 193~201    
  • 박한진 (8)

  • 오정화 (6)

  • 김충용 (11)

  • Yoon, Seok-Joo (15)

 활용도 분석

  • 상세보기

    amChart 영역
  • 원문보기

    amChart 영역


  • NDSL :
  • 원문이 없습니다.

유료 다운로드의 경우 해당 사이트의 정책에 따라 신규 회원가입, 로그인, 유료 구매 등이 필요할 수 있습니다. 해당 사이트에서 발생하는 귀하의 모든 정보활동은 NDSL의 서비스 정책과 무관합니다.

원문복사신청을 하시면, 일부 해외 인쇄학술지의 경우 외국학술지지원센터(FRIC)에서
무료 원문복사 서비스를 제공합니다.

NDSL에서는 해당 원문을 복사서비스하고 있습니다. 위의 원문복사신청 또는 장바구니 담기를 통하여 원문복사서비스 이용이 가능합니다.

이 논문과 함께 출판된 논문 + 더보기